These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques. Bajgar J; Hajek P; Zdarova JK; Kassa J; Paseka A; Slizova D; Krs O; Kuca K; Jun D; Fusek J; Capek L J Enzyme Inhib Med Chem; 2010 Dec; 25(6):790-7. PubMed ID: 21054236 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406 [TBL] [Abstract][Full Text] [Related]
6. Reactivation of human brain homogenate cholinesterases inhibited by Tabun using newly developed oximes K117 and K127. Kuca K; Cabal J; Jung YS; Musilek K; Soukup O; Jun D; Pohanka M; Musilova L; Karasová J; Novotný L; Hrabinova M Basic Clin Pharmacol Toxicol; 2009 Sep; 105(3):207-10. PubMed ID: 19473310 [TBL] [Abstract][Full Text] [Related]
7. [A comparison of the efficacy of the reactivators of acetylcholinesterase inhibited with tabun]. Cabal J; Kuca K; Jun D; Bajgar J; Hrabinová M Ceska Slov Farm; 2005 Jul; 54(4):192-5. PubMed ID: 16124202 [TBL] [Abstract][Full Text] [Related]
8. Potency of five structurally different acetylcholinesterase reactivators to reactivate human brain cholinesterases inhibited by cyclosarin. Kuca K; Cabal J; Jun D; Hrabinova M Clin Toxicol (Phila); 2007; 45(5):512-5. PubMed ID: 17503257 [TBL] [Abstract][Full Text] [Related]
9. Oxime K027: novel low-toxic candidate for the universal reactivator of nerve agent- and pesticide-inhibited acetylcholinesterase. Kuca K; Musilek K; Jun D; Pohanka M; Ghosh KK; Hrabinova M J Enzyme Inhib Med Chem; 2010 Aug; 25(4):509-12. PubMed ID: 20192902 [TBL] [Abstract][Full Text] [Related]
10. In vitro reactivation of acetylcholinesterase inhibited by cyclosarin using bisquaternary pyridinium aldoximes K005, K033, K027 AND K048. Kuca K; Sevelová-Bartosová L; Krejcová-Kunesová G Acta Medica (Hradec Kralove); 2004; 47(2):107-9. PubMed ID: 15446359 [TBL] [Abstract][Full Text] [Related]
11. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778 [TBL] [Abstract][Full Text] [Related]
12. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice. Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085 [TBL] [Abstract][Full Text] [Related]
13. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Kassa J; Karasova J; Musilek K; Kuca K Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821 [TBL] [Abstract][Full Text] [Related]
14. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice. Kassa J; Karasova J; Bajgar J; Kuca K; Musilek K; Kopelikova I J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1040-4. PubMed ID: 19552519 [TBL] [Abstract][Full Text] [Related]
15. Potency of novel oximes to reactivate sarin inhibited human cholinesterases. Jun D; Kuca K; Picha J; Koleckar V; Marek J Drug Chem Toxicol; 2008; 31(1):1-9. PubMed ID: 18161504 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats. Kassa J; Kunesova G J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods. Kuca K; Cabal J; Kassa J Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060 [TBL] [Abstract][Full Text] [Related]
18. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning. Kovarik Z; Calić M; Sinko G; Bosak A; Berend S; Vrdoljak AL; Radić B Chem Biol Interact; 2008 Sep; 175(1-3):173-9. PubMed ID: 18501341 [TBL] [Abstract][Full Text] [Related]
19. Effect of five acetylcholinesterase reactivators on tabun-intoxicated rats: induction of oxidative stress versus reactivation efficacy. Pohanka M; Karasova JZ; Musilek K; Kuca K; Kassa J J Appl Toxicol; 2009 Aug; 29(6):483-8. PubMed ID: 19338015 [TBL] [Abstract][Full Text] [Related]
20. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods. Kassa J; Kuca K; Cabal J; Paar M J Toxicol Environ Health A; 2006 Oct; 69(20):1875-82. PubMed ID: 16952906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]